ADMA FY 2010 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$20,530

Net Income

-$20,526

EPS (Diluted)

$-0.00

Cash Flow

Operating Cash Flow

-$19,676

Free Cash Flow

-$19,676

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$12,012

Total Liabilities

$12,358

Stockholders' Equity

-$346

Cash & Equivalents

$12,012

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$20,530	-$20M	+99.9%
Net Income	-$20,526	-$20M	+99.9%